Boardroom Alpha
Start trial
← Activism
Activist profile

Caligan Partners LP

Campaigns
••
Proxy fights
••
Settlements
••
Directors placed
••
Style
••
Unlock the full track record →

Caligan Partners LP is one of the U.S. shareholder activists tracked by Boardroom Alpha, with disclosed campaigns dating to 2019. Recent U.S. targets include Anika Therapeutics Inc and Knowles Corp.

Recent activity

Notable Campaigns

2024ANIKAnika Therapeutics IncCooperation agreement
2023ANIKAnika Therapeutics IncCooperation agreement
2019KNKnowles CorpCooperation agreement

Full campaign history, dissident slates, per-nominee seat outcomes, and filings timelines inside the platform →

Current positions

Top Holdings

Q ending Mar 31, 2026
ANIKAnika Therapeutics Inc
$21M
SABSSab Biotherapeutics Inc
$31M
SNSESensei Biotherapeutics Inc
$4M
LQDALiquidia Technologies, Inc.
$306M
IRDOpus Genetics Inc
$28M

Full portfolio, position changes by quarter, and overlap with Caligan’s likely next targets inside the platform →

Last 12 months

Recent SEC Filings

Portfolio (13F)
Voting (N-PX)

Full filings history with parsed positions, voting records, and dissident-proxy timelines inside the platform →

View all filings on SEC EDGAR ↗
From our research

Recent coverage of Caligan Partners

Boardroom Alpha analysis
Compare

Related activists

Linked profiles
Elliott Investment Management L.P.Engaged CapitalAncora Advisors, LLCStarboard ValueTrian Fund ManagementLegion Partners Asset ManagementBarington Capital GroupEngine Capital, L.P.
Inside Boardroom Alpha

The full Caligan Partners LP profile

  • →Daily-rescored target prediction from the activist's current 13F overlap
  • →Full detail on every activist board nominee and the election or settlement result
  • →Per-campaign effectiveness scoring across vote outcomes and concessions
  • →Composite influence, vote-strength, and negotiating-leverage scoring
  • →Preferred legal counsel, proxy solicitor, and IR/PR provider history
Request a demoOpen in platform →
Back to research